Member of Farmavita.net have under development registration dossier in European CTD format for Bleomycin, 15-30 units, injection with lyophilized powder.
Bleomycin is antineoplastic and immunomodulating medicine accroding ATC index.
License for use of Dossier is related to commitment of bulk supply.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights
|Pharma licensing||Out-licensing (offer)|